dihydroxyphenylalanine has been researched along with DiGeorge Syndrome in 1 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
DiGeorge Syndrome: Congenital syndrome characterized by a wide spectrum of characteristics including the absence of the THYMUS and PARATHYROID GLANDS resulting in T-cell immunodeficiency, HYPOCALCEMIA, defects in the outflow tract of the heart, and craniofacial anomalies.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Rogdaki, M | 1 |
Devroye, C | 1 |
Ciampoli, M | 1 |
Veronese, M | 1 |
Ashok, AH | 1 |
McCutcheon, RA | 1 |
Jauhar, S | 1 |
Bonoldi, I | 1 |
Gudbrandsen, M | 1 |
Daly, E | 1 |
van Amelsvoort, T | 1 |
Van Den Bree, M | 1 |
Owen, MJ | 1 |
Turkheimer, F | 1 |
Papaleo, F | 1 |
Howes, OD | 1 |
1 other study available for dihydroxyphenylalanine and DiGeorge Syndrome
Article | Year |
---|---|
Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET study.
Topics: DiGeorge Syndrome; Dihydroxyphenylalanine; DNA Copy Number Variations; Dopamine; Humans; Positron-Em | 2023 |